-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCONANO MEDICINE: GILEAD HAS OPTION TO EXPAND DEAL BY NOMINATING ADDITIONAL TARGET FOR ON-BOARD TECHNOLOGY, IN WHICH CO WOULD RECEIVE UP TO $300 MLN

Reuters·01/06/2026 12:03:42

Please log in to view news